New drug combo aims to control aggressive blood cancer in seniors
NCT ID NCT04765111
Summary
This study is testing whether a combination of two drugs, acalabrutinib and rituximab, can effectively control mantle cell lymphoma in older adults who have not yet received any treatment. The goal is to see how well this drug pair works to put the cancer into remission and to understand its side effects. The trial is for patients aged 65 and older with this specific type of blood cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MANTLE CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.